Saturday, December 06, 2025 | 12:40 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Covid-19: ICMR invites application for validation of rapid antigen tests

So far, ICMR has validated and approved only one rapid antigen detection assay from SD Biosensor, a South Korea based company, having its manufacturing unit in Manesar,Gurgaon

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
premium

All hospitals, labs, state governments intending to perform the point-of-care antigen test need to register with ICMR to obtain the login credentials for data entry

Press Trust of India New Delhi

The ICMR on Thursday invited applications for validation of rapid antigen detection tests for Covid-19from all manufacturers who have developed such kits as part of its efforts to scale up testing capacity with faster diagnosis.

The rapid antigen test allows faster diagnosis without laboratory examination of samples and results are available within 30minutes.

The ICMR has identified six sites -- AIIMS, Delhi; SMS Medical College in Jaipur; King George Medical University, Lucknow; Kasturba Hospital for Infectious Diseases, Mumbai;PGIMER inChandigarh; Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry and NIV, Kerala unit, Alappuzha -- for validation of the rapid point-of-care antigen detection

Topics : Coronavirus